Skip to main content
Fig. 8 | Respiratory Research

Fig. 8

From: An ICD-Associated DAMP Gene signature predicts survival and immunotherapy response of patients with lung adenocarcinoma

Fig. 8

Construction of a nomogram combined with clinical characteristics in TCGA and GEO datasets. (A) The predictive nomogram built in combination with the risk signature and clinical characteristics predicted one-, three- and five-year OS and PFS of patients with LUAD in TCGA dataset. (B) The predictive nomogram built in combination with the risk signature and clinical characteristics predicted one-, three- and five-year OS and DFS of patients with LUAD in GSE31210. (C) The probabilities of OS and PFS at one-, three- and five- years were assessed by calibration plots of the nomogram in TCGA dataset. (D) The probabilities of OS and DFS at one-, three- and five- years were assessed by calibration plots of the nomogram in GSE31210. (E) ROC curves of the nomograms compared with clinical stage and risk score with regard to one-, three- and five-year survival in TCGA dataset. (F) ROC curves of the nomograms compared with clinical stage and risk score with regard to one-, three- and five-year survival in GSE31210. OS, overall survival; PFS, progression-free survival; DFS, disease-free survival

Back to article page